Cargando…

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism

BACKGROUND: Dogs treated for naturally occurring hyperadrenocorticism (NOH) in Korea often appear to require higher doses of trilostane than recommended by authors in the United States, Europe, or the United Kingdom. This phenomenon may be related to compounding trilostane into packets, which is a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Sookin, Kim, Tae‐won, Song, Kun‐ho, Feldman, Edward C., Seo, Kyoung‐won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295693/ https://www.ncbi.nlm.nih.gov/pubmed/34114230 http://dx.doi.org/10.1111/jvim.16197

Ejemplares similares

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
por: Nagata, N., et al.
Publicado: (2016)

Evaluation of individual low‐dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs
por: Bennaim, Michael, et al.
Publicado: (2018)

Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
por: Golinelli, Stefania, et al.
Publicado: (2021)

Clinical features of muscle stiffness in 37 dogs with concurrent naturally occurring hypercortisolism
por: Golinelli, Stefania, et al.
Publicado: (2023)

Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
por: García San José, Paula, et al.
Publicado: (2020)

Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism
por: Aldridge, C., et al.
Publicado: (2016)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Clinical Relationship between Cholestatic Disease and Pituitary‐Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series
por: Kim, K.‐h., et al.
Publicado: (2017)

Comparison of Adrenocorticotropic Hormone Stimulation Test Results Started 2 versus 4 Hours after Trilostane Administration in Dogs with Naturally Occurring Hyperadrenocorticism
por: Bonadio, C.M., et al.
Publicado: (2014)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

The interpretive contribution of the baseline serum cortisol concentration of the ACTH stimulation test in the diagnosis of pituitary dependent hyperadrenocorticism in dogs
por: Nivy, Ran, et al.
Publicado: (2018)

Utility of a corticotropin‐releasing hormone test to differentiate pituitary‐dependent hyperadrenocorticism from cortisol‐producing adrenal tumors in dogs
por: Tanaka, Sachiyo, et al.
Publicado: (2021)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

Efficacy of Minocycline in Naturally Occurring Nonacute Ehrlichia canis Infection in Dogs
por: Jenkins, S., et al.
Publicado: (2017)

Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism
por: Corsini, Andrea, et al.
Publicado: (2021)

Serum triglyceride and cholesterol concentrations and lipoprotein profiles in dogs with naturally occurring pancreatitis and healthy control dogs
por: Xenoulis, Panagiotis G., et al.
Publicado: (2020)

Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease
por: Hall, J.A., et al.
Publicado: (2016)

Protease inhibitors, inflammatory markers, and their association with outcome in dogs with naturally occurring acute pancreatitis
por: Kuzi, Sharon, et al.
Publicado: (2020)

Naturally Occurring Adrenocortical Insufficiency – An Epidemiological Study Based on a Swedish‐Insured Dog Population of 525,028 Dogs
por: Hanson, J.M., et al.
Publicado: (2016)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogs
por: Seo, Do‐Hyun, et al.
Publicado: (2018)

Dominant outflow vein occlusion in the management of naturally occurring peripheral arteriovenous anomalies in cats and dogs
por: Hyndman, Philip S., et al.
Publicado: (2021)

Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2023)

Endothelin‐1 Immunoreactivity and its Association with Intramedullary Hemorrhage and Myelomalacia in Naturally Occurring Disk Extrusion in Dogs
por: Mayer, D., et al.
Publicado: (2016)

Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism
por: Tinted, Nannicha, et al.
Publicado: (2023)

Correlation of Urine and Serum Biomarkers with Renal Damage and Survival in Dogs with Naturally Occurring Proteinuric Chronic Kidney Disease
por: Hokamp, J.A., et al.
Publicado: (2016)

Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma
por: Samuel, Nina, et al.
Publicado: (2022)

Naturally Occurring Biventricular Noncompaction in an Adult Domestic Cat
por: Kittleson, M.D., et al.
Publicado: (2017)

Urine hemojuvelin in cats with naturally occurring kidney disease
por: Jing, Hwei, et al.
Publicado: (2020)

Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment
por: Muschner, Adriana Cunha, et al.
Publicado: (2018)

Long‐Term Survival of Dogs with Adrenal‐Dependent Hyperadrenocorticism: A Comparison between Mitotane and Twice Daily Trilostane Treatment
por: Arenas, C., et al.
Publicado: (2014)

Thymidine Kinase Type 1 and C‐Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer
por: Selting, K.A., et al.
Publicado: (2016)

Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs
por: Macfarlane, L., et al.
Publicado: (2016)

Ultrasonographic patterns, clinical findings, and prognostic variables in dogs from Asia with gallbladder mucocele
por: Jaffey, Jared A., et al.
Publicado: (2022)

Neutrophil Gelatinase‐Associated Lipocalin in Cats with Naturally Occurring Chronic Kidney Disease
por: Wang, I.‐C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_178l7pjikj8t0hc3te3horgte4